|
1
|
Gao J and Liu WJ: Prognostic value of the
response to prednisone for children with acute lymphoblastic
leukemia: A meta-analysis. Eur Rev Med Pharmacol Sci. 22:7858–7866.
2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Terwilliger T and Abdul-Hay M: Acute
lymphoblastic leukemia: A comprehensive review and 2017 update.
Blood Cancer J. 7(e577)2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Papadantonakis N and Advani AS: Recent
advances and novel treatment paradigms in acute lymphocytic
leukemia. Ther Adv Hematol. 7:252–269. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Matloub Y, Stork L, Asselin B, Hunger SP,
Borowitz M, Jones T, Bostrom B, Gastier-Foster JM, Heerema NA,
Carroll A, et al: Outcome of children with standard-risk T-lineage
acute lymphoblastic leukemia-comparison among different treatment
strategies. Pediatr Blood Cancer. 63:255–261. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Qin X, Zhang MY and Liu WJ: Application of
minimal residual disease monitoring in pediatric patients with
acute lymphoblastic leukemia. Eur Rev Med Pharmacol Sci.
22:6885–6895. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wang M, Wen J, Guo Y, Shen Y, An X, Hu Y
and Xiao J: Clinical characterization and prognosis of T cell acute
lymphoblastic leukemia with high CRLF2 gene expression in Children.
PLoS One. 14(e0224652)2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Takahashi H, Kajiwara R, Kato M, Hasegawa
D, Tomizawa D, Noguchi Y, Koike K, Toyama D, Yabe H, Kajiwara M, et
al: Treatment outcome of children with acute lymphoblastic
leukemia: The Tokyo Children's Cancer Study Group (TCCSG) Study
L04-16. Int J Hematol. 108:98–108. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Li Y, Buijs-Gladdines JG, Canté-Barrett K,
Stubbs AP, Vroegindeweij EM, Smits WK, van Marion R, Dinjens WN,
Horstmann M, Kuiper RP, et al: IL-7 receptor mutations and steroid
resistance in pediatric T cell acute lymphoblastic leukemia: A
genome sequencing study. PLoS Med. 13(e1002200)2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Raetz EA and Teachey DT: T-cell acute
lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program.
2016:580–588. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Punzo F, Manzo I, Tortora C, Pota E,
Angelo V, Bellini G, Di Paola A, Verace F, Casale F and Rossi F:
Effects of CB2 and TRPV1 receptors' stimulation in pediatric acute
T-lymphoblastic leukemia. Oncotarget. 9:21244–21258.
2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Tosello V and Ferrando A: The NOTCH
signaling pathway: Role in the pathogenesis of T-cell acute
lymphoblastic leukemia and implication for therapy. Ther Adv
Hematol. 4:199–210. 2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Juliusson G and Hough R: Leukemia. Prog
Tumor Res. 43:87–100. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Tan SH, Bertulfo FC and Sanda T:
Leukemia-initiating cells in T-cell acute lymphoblastic leukemia.
Front Oncol. 7(218)2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Rose-Inman H and Kuehl D: Acute leukemia.
Hematol Oncol Clin North Am. 31:1011–1028. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kuhlen M, Klusmann JH and Hoell JI:
Molecular approaches to treating pediatric leukemias. Front
Pediatr. 7(368)2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang Y, Chen H and Chen J: The consensus
on the monitoring, treatment, and prevention of leukemia relapse
after allogeneic hematopoietic stem cell transplantation in China.
Cancer Lett. 438:63–75. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Peters C, Cornish JM, Parikh SH and
Kurtzberg J: Stem cell source and outcome after hematopoietic stem
cell transplantation (HSCT) in children and adolescents with acute
leukemia. Pediatr Clin North Am. 57:27–46. 2010.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Wang GYS, Abrell LM, Avelar A, Borgeson BM
and Crews P: New hirsutane based sesquiterpenes from salt water
cultures of a marine sponge-derived fungus and the terrestrial
fungus Coriolus consors. Tetrahedron. 26:7335–7342. 1998.
|
|
19
|
Li HJ, Lan WJ, Lam CK, Yang F and Zhu XF:
Hirsutane sesquiterpenoids from the marine-derived fungus
Chondrostereum sp. Chem Biodivers. 8:317–324.
2011.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Yang F, Chen WD, Deng R, Li DD, Wu KW,
Feng GK, Li HJ and Zhu XF: Hirsutanol A induces apoptosis and
autophagy via reactive oxygen species accumulation in breast cancer
MCF-7 cells. J Pharmacol Sci. 119:214–220. 2012.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wenzel ES and Singh ATK: Cell-cycle
checkpoints and aneuploidy on the path to cancer. In Vivo. 32:1–5.
2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wang Y, Zhong J, Bai J, Tong R, An F, Jiao
P, He L, Zeng D, Long E, Yan J, et al: The application of natural
products in cancer therapy by targeting apoptosis pathways. Curr
Drug Metab. 19:739–749. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Green DR and Reed JC: Mitochondria and
apoptosis. Science. 281:1309–1312. 1998.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Sinha K, Das J, Pal PB and Sil PC:
Oxidative stress: The mitochondria-dependent and
mitochondria-independent pathways of apoptosis. Arch Toxicol.
87:1157–1180. 2013.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Julien O and Wells JA: Caspases and their
substrates. Cell Death Differ. 24:1380–1389. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ranjan A and Iwakuma T: Non-canonical cell
death induced by p53. Int J Mol Sci. 17(2068)2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Abdelmabood S, Fouda AE, Boujettif F and
Mansour A: Treatment outcomes of children with acute lymphoblastic
leukemia in a middle-income developing country: High mortalities,
early relapses, and poor survival. J Pediatr (Rio J). 96:108–116.
2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Khalifa SAM, Elias N, Farag MA, Chen L,
Saeed A, Hegazy MF, Moustafa MS, Abd El-Wahed A, Al-Mousawi SM,
Musharraf SG, et al: Marine natural products: A source of novel
anticancer drugs. Mar Drugs. 17(491)2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Yang F, Gao YH, Wu KW, Deng R, Li DD, Wei
ZX, Jiang S, Wu XQ, Feng GK, Li HJ and Zhu XF: A novel
sesquiterpene Hirsutanol A induces autophagical cell death in human
hepatocellular carcinoma cells by increasing reactive oxygen
species. Chin J Cancer. 29:655–660. 2010.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Yang F, Chen WD, Deng R, Zhang H, Tang J,
Wu KW, Li DD, Feng GK, Lan WJ, Li HJ and Zhu XF: Hirsutanol A, a
novel sesquiterpene compound from fungus Chondrostereum sp.,
induces apoptosis and inhibits tumor growth through
mitochondrial-independent ROS production: Hirsutanol A inhibits
tumor growth through ROS production. J Transl Med.
11(32)2013.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Li HJ, Jiang WH, Liang WL, Huang JX, Mo
YF, Ding YQ, Lam CK, Qian XJ, Zhu XF and Lan WJ: Induced marine
fungus Chondrostereum sp. as a means of producing new
sesquiterpenoids chondrosterins I and J by using glycerol as the
carbon source. Mar Drugs. 12:167–175. 2014.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Correia C, Lee SH, Meng XW, Vincelette ND,
Knorr KL, Ding H, Nowakowski GS, Dai H and Kaufmann SH: Emerging
understanding of Bcl-2 biology: Implications for neoplastic
progression and treatment. Biochim Biophys Acta. 1853:1658–1671.
2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Porter AG and Jänicke RU: Emerging roles
of caspase-3 in apoptosis. Cell Death Differ. 6:99–104.
1999.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Wang Y, Liu C, Wang J, Zhang Y and Chen L:
Iodine-131 induces apoptosis in human cardiac muscle cells through
the p53/Bax/caspase-3 and PIDD/caspase-2/t-BID/cytochrome
c/caspase-3 signaling pathway. Oncol Rep. 38:1579–1586.
2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Burke PJ: Mitochondria, bioenergetics and
apoptosis in cancer. Trends Cancer. 3:857–870. 2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Tichy A, Marek J, Havelek R, Pejchal J,
Seifrtova M, Zarybnicka L, Filipova A, Rezacova M and Sinkorova Z:
New light on an old friend: Targeting PUMA in radioprotection and
therapy of cardiovascular and neurodegenerative diseases. Curr Drug
Targets. 19:1943–1957. 2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Vávrová J and Rezáčová M: Importance of
proapoptotic protein PUMA in cell radioresistance. Folia Biol
(Praha). 60:53–56. 2014.PubMed/NCBI
|
|
38
|
Hickman ES, Moroni MC and Helin K: The
role of p53 and pRB in apoptosis and cancer. Curr Opin Genet Dev.
12:60–66. 2002.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Brázda V and Fojta M: The rich world of
p53 DNA binding targets: The role of DNA structure. Int J Mol Sci.
20(5605)2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Riley T, Sontag E, Chen P and Levine A:
Transcriptional control of human p53-regulated genes. Nat Rev Mol
Cell Biol. 9:402–412. 2008.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Matt S and Hofmann TG: The DNA
damage-induced cell death response: A roadmap to kill cancer cells.
Cell Mol Life Sci. 73:2829–2850. 2016.PubMed/NCBI View Article : Google Scholar
|
